Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sunphenon EGCG is a high-purity, decaffeinated green tea extract standardized to contain more than 94% epigallocatechin gallate (EGCg), the major catechin found in green tea leaves (Camellia sinensis)[3][4][9]. It is produced via water infusion and decaffeination using food-grade solvents to ensure compliance with stringent safety standards[1][9]. Sunphenon EGCG is marketed as a 100% natural ingredient for use in dietary supplements, functional foods and beverages, and cosmetics[3][4]. The primary mechanism of action of EGCg involves its antioxidant activity—scavenging free radicals and reducing oxidative stress. Additional reported effects include anti-inflammatory activity, thermogenic effects that may aid weight management, antimicrobial properties, and potential cardiovascular benefits[8][9]. Clinical studies have explored its use in conditions such as relapsing-remitting multiple sclerosis[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sunphenon EGCG.